Dividend compounder review

DCPH

Deciphera Pharmaceuticals LLC · NASDAQ · US

Healthcare · Drug Manufacturers - Specialty & Generic

Score9.50/100
Confidence42.00/100
DecisionInsufficient Data
RatingAvoid
Scoring

Quality breakdown

Dividend Reliability 0.0 / 25 Payment history, cuts, growth, and regularity.
Dividend Sustainability 3.0 / 20 Payout, free cash flow, dividend cover, and debt.
Business Quality 6.5 / 25 Scale, cash generation, growth, margins, and returns.
Valuation Discipline 0.0 / 15 Yield, P/E, and price stretch versus long-term trend.
Long-Term Trend 0.0 / 15 Trend line, long return history, and drawdown control.
Metrics

Dividend and business context

Dividend Years0
Dividend Yield0.00%
Payout Ratio-
Dividend Cut 5YNo
Net Income$-190.4M
Free Cash Flow$-151.3M
FCF Covers DividendUnknown
Debt / Equity0.33
P/E-
Revenue Growth 5Y-
Net Margin-108.9%
ROE-60.2%
Price vs Trend-
3Y Return-
5Y Return-
CurrencyUSD
Warnings

Review flags

No usable dividend history found.
Payout ratio unavailable.
Free cash flow is negative.
Less than five years of weekly price history available.
Dividend diary

Activity record

DCPH dividend review warning Warning · Warning

Less than five years of weekly price history available.